Godavari Biorefineries Ltd
Incorporated in 1939, Godavari Biorefineries Ltd is a manufacturer of Bio-based Chemicals and Ethanol[1]
- Market Cap ₹ 1,157 Cr.
- Current Price ₹ 226
- High / Low ₹ 354 / 194
- Stock P/E 40.1
- Book Value ₹ 147
- Dividend Yield 0.00 %
- ROCE 6.43 %
- ROE 4.08 %
- Face Value ₹ 10.0
Pros
- Debtor days have improved from 29.6 to 20.9 days.
Cons
- Company has low interest coverage ratio.
- The company has delivered a poor sales growth of 5.26% over past five years.
- Company has a low return on equity of 1.05% over last 3 years.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|
| 1,459 | 1,538 | 1,702 | 2,015 | 1,687 | 1,870 | 1,988 | 2,131 | |
| Sales growth | +5% | +11% | +18% | -16% | +11% | +6% | +7% | |
| 1,356 | 1,381 | 1,568 | 1,867 | 1,553 | 1,766 | 1,860 | 1,991 | |
| Operating Profit | 103 | 158 | 134 | 147 | 134 | 104 | 128 | 140 |
| OPM % | 7% | 10% | 8% | 7% | 8% | 6% | 6% | 7% |
| 14 | 8 | 6 | 7 | 14 | 16 | -20 | 6 | |
| Interest | 69 | 72 | 60 | 73 | 76 | 72 | 49 | 51 |
| Depreciation | 45 | 47 | 48 | 50 | 60 | 50 | 54 | 57 |
| Profit before tax | 3 | 46 | 32 | 32 | 12 | -2 | 5 | 38 |
| Tax % | -24% | 41% | 40% | 38% | 1% | 1,421% | 23% | |
| 4 | 27 | 19 | 20 | 12 | -23 | 4 | 27 | |
| EPS in Rs | 0.97 | 6.47 | 4.55 | 4.68 | 2.93 | -4.57 | 0.69 | 5.18 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 5% |
| 3 Years: | 0% |
| TTM: | 7% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 4% |
| 3 Years: | 17% |
| TTM: | -38% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | -10% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | 2% |
| 3 Years: | 1% |
| Last Year: | 4% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | Sep 2026 | |
|---|---|---|---|---|---|---|---|---|
| Equity Capital | 42 | 42 | 42 | 42 | 42 | 51 | 51 | 51 |
| Reserves | 385 | 412 | 431 | 448 | 459 | 731 | 737 | 702 |
| 589 | 569 | 636 | 736 | 655 | 490 | 531 | 546 | |
| 418 | 419 | 625 | 518 | 836 | 683 | 733 | 322 | |
| Total Liabilities | 1,434 | 1,442 | 1,734 | 1,744 | 1,992 | 1,955 | 2,052 | 1,621 |
| 735 | 708 | 667 | 866 | 850 | 862 | 866 | 983 | |
| CWIP | 17 | 9 | 50 | 17 | 29 | 37 | 148 | 55 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 683 | 725 | 1,016 | 860 | 1,113 | 1,055 | 1,038 | 583 | |
| Total Assets | 1,434 | 1,442 | 1,734 | 1,744 | 1,992 | 1,955 | 2,052 | 1,621 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| 250 | 130 | 45 | 197 | 185 | -0 | 171 | |
| -23 | -7 | -48 | -214 | -44 | -62 | -163 | |
| -226 | -121 | 6 | 28 | -151 | 64 | -6 | |
| Net Cash Flow | 1 | 2 | 3 | 11 | -10 | 1 | 3 |
| Free Cash Flow | 223 | 119 | -5 | -20 | 130 | -72 | 6 |
| CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit | 242% | 82% | 34% | 135% | 140% | 5% | 135% |
Ratios
Consolidated / View Standalone
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Debtor Days | 31 | 40 | 37 | 37 | 41 | 27 | 21 |
| Inventory Days | 130 | 146 | 200 | 137 | 250 | 195 | 198 |
| Days Payable | 123 | 132 | 176 | 105 | 195 | 140 | 146 |
| Cash Conversion Cycle | 39 | 55 | 61 | 68 | 95 | 82 | 74 |
| Working Capital Days | -68 | 1 | 3 | 2 | -14 | 22 | 16 |
| ROCE % | 12% | 9% | 9% | 7% | 6% | 6% |
Insights
In beta| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|
| Cane Crushing Volume Lakh Metric Tonnes |
|
|||||||
| Distillery Capacity KLPD |
||||||||
| Sugar Recovery Rate % |
||||||||
| Sugar Crushing Capacity TCD |
||||||||
| Specialty Chemicals Share of Bio-Based Chemicals Revenue % |
||||||||
| Ethanol Sales Volume KL |
||||||||
| Jivana Retail Store Count number |
||||||||
| Sugar Production Volume MT |
||||||||
Extracted by Screener AI
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
- Audio recording of Q2 and H1 FY27 earnings conference call uploaded on November 6, 2026.
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
- Copy of newspaper publication of Q2 and H1 of FY 27 financial Results
-
Announcement under Regulation 30 (LODR)-Investor Presentation
- Investor Presentation for Q2 and H1 of FY 27
-
Announcement under Regulation 30 (LODR)-Press Release / Media Release
- Godavari Biorefineries reported Q2 FY27 revenue of Rs. 549.8 crore and EBITDA of Rs. 10.9 crore.
-
Unaudited Financial Results For The Quarter And Half Year Ended 30Th September, 2026
- Board approved Q2/H1 FY27 unaudited results on 4 Nov 2026; consolidated loss ₹15.24 crore in Q2.
Annual reports
-
Annual Report 2026
from bse
-
Annual Report 2025
from bse
-
Annual Report 2024
from web
-
Annual Report 2023
from web
-
Annual Report 2022
from web
-
Annual Report 2021
from web
-
Annual Report 2020
from web
Concalls
-
Nov 2026PPT REC
-
Aug 2026PPT REC
-
Jun 2026Transcript PPT
-
Feb 2026Transcript PPT
-
Nov 2025Transcript PPT
-
Aug 2025Transcript PPT
-
May 2025Transcript PPT REC
-
May 2025PPT
-
Feb 2025Transcript PPT REC
-
Nov 2024Transcript PPT REC
Business Overview:[1][2]
a) GBL is a part of the Somaiya group which holds 63.31% equity stake in the company through entities.
b) It has an Integrated Bio-refinery across value chain viz. Sugar, Branded Sugar, Ethanol, Bio Based Chemicals & Power
c) It has India’s first bio-based Ethyl Vinyl Ether (EVE) manufacturing facility in India
d) Company is the largest Manufacturer of MPO in India in terms of installed capacity
e) It is one of only 2 Manufacturers of natural 1,3 Butylene Glycol (BG) globally
f) The company has an in-house retail brand Jivana for sale of sugar, turmeric, and salt in Rajasthan Maharashtra, Karnataka, and Gujarat.